M. Maimets

发表

Surgical-Site Infections Following Cesarean Section in an Estonian University Hospital: Postdischarge Surveillance and analysis of Risk Factors

P. Mitt, K. Lang, Aira Peri, 2005, Infection Control & Hospital Epidemiology.

Prolonged outbreak of Serratia marcescens in Tartu University Hospital: a case–control study

P. Naaber, T. Metsvaht, P. Mitt, 2012, BMC Infectious Diseases.

1 PROLONGED OUTBREAK OF SERRATIA MARCESCENS IN TARTU UNIVERSITY HOSPITAL : A CASE-CONTROL STUDY

P. Naaber, T. Metsvaht, P. Mitt, 2012 .

Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals

T. Tenson, M. Remm, I. Lutsar, 2018, BMC Infectious Diseases.

HIV incidence in the Estonian population in 2013 using the HIV-1 Limiting Antigen Avidity ( LAg ) assay

E. Kallas, R. Avi, K. Huik, 2018 .

Strategies to manage hepatitis C virus infection disease burden – volume 3

R. Malekzadeh, K. Han, S. Olafsson, 2015, Journal of viral hepatitis.

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.

J. Lazarus, R. Marinho, S. Olafsson, 2018, The lancet. Gastroenterology & hepatology.

HIV incidence in the Estonian population in 2013 determined using the HIV‐1 limiting antigen avidity assay

R. Avi, K. Huik, I. Lutsar, 2018, HIV medicine.

Epidemiology of nosocomial bloodstream infections in Estonia.

P. Naaber, K. Lõivukene, P. Mitt, 2009, The Journal of hospital infection.

Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe

J. Lazarus, R. Marinho, S. Olafsson, 2017 .

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Gamal Esmat, Rui Tato Marinho, Mel Krajden, 2017, The lancet. Gastroenterology & hepatology.

Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3

R. Malekzadeh, K. Han, S. Olafsson, 2015, Journal of viral hepatitis.

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

M. Manns, V. de Lédinghen, M. Buti, 2017, The lancet. Gastroenterology & hepatology.

Characteristics of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae and Contact to Animals in Estonia

T. Tenson, M. Remm, I. Lutsar, 2020, Microorganisms.

Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999-2003.

P. Naaber, I. Lutsar, S. Kõljalg, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3

D. Y. Kim, M. A. Sultan, R. Malekzadeh, 2015, Journal of viral hepatitis.

Antibiotic use in 3 European university hospitals.

B. Wettermark, R. Berecz, A. Llerena, 1998, Scandinavian journal of infectious diseases.

Antibiotic usage and resistance - trends in Estonian University Hospitals.

M Maimets, P. Naaber, S. Kõljalg, 2000, International journal of antimicrobial agents.

Design and structure of the Estonian HIV Cohort Study (E-HIV)

R. Avi, K. Huik, I. Lutsar, 2015, Infectious diseases.

Epidemiology of nosocomial bloodstream infections in Estonia.

P. Naaber, P. Mitt, M. Maimets, 2009, The Journal of hospital infection.

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

S. Alavian, M. Manns, Chien-Jen Chen, 2017, The lancet. Gastroenterology & hepatology.

Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children.

P. Naaber, S. Kõljalg, E. Tamm, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.